ArticlePDF Available

Tongkat Ali as a Potential Herbal Supplement for Physically Active Male and Female Seniors-A Pilot Study

Authors:

Abstract and Figures

Tongkat Ali (Eurycoma longifolia; TA) is known to increase testosterone levels and alleviate aging males' symptoms. This study aimed at investigating TA as an ergogenic supplement for elderly people. Thirteen physically active male and 12 physically active female seniors (57-72 years) were supplemented with 400-mg TA extract daily for 5 weeks. Standard hematological parameters were taken. In addition, the concentrations of total and free testosterone, dihydroepiandrosterone, cortisol, insulin-like growth factor-1, and sex hormone-binding globulin were analyzed. As additional biochemical parameters, blood urea nitrogen and creatine kinase as parameters of kidney function and muscle damage, respectively, as well as the muscle strength by a simple handgrip test were determined. After treatment, hemoglobin, testosterone, and dihydroepiandrosterone concentrations, and the ratio of total testosterone/cortisol and muscle force remained significantly lower in female seniors than in male seniors. Hematocrit and erythrocyte count in male seniors increased slightly but were significantly higher than in female seniors. Treatment resulted in significant increases in total and free testosterone concentrations and muscular force in men and women. The increase in free testosterone in women is thought to be due to the significant decline in sex hormone-binding globulin concentrations. The study affirms the ergogenic benefit of TA through enhanced muscle strength. Copyright © 2013 John Wiley & Sons, Ltd.
Content may be subject to copyright.
Tongkat Ali as a Potential Herbal Supplement for
Physically Active Male and Female SeniorsA
Pilot Study
Ralf R. Henkel,
1
*
Ruxiang Wang,
2
Susan H. Bassett,
3
Tao Chen,
4
Na Liu,
2
Ying Zhu
4
and
Mohd Ismail Tambi
5
1
Department of Medical Bioscience, University of the Western Cape, Bellville 7535, South Africa
2
Shenyang Center for Disease Control and Prevention, Shenyang, China
3
Department of Sport, Recreation and Exercise Science, University of the Western Cape, Bellville 7535, South Africa
4
Liaoning Sport Science Institute, Shenyang, China
5
Wellmen Clinic, Damai Service Hospital, Kuala Lumpur 52100, Malaysia
Tongkat Ali (Eurycoma longifolia; TA) is known to increase testosterone levels and alleviate aging males
symptoms. This study aimed at investigating TA as an ergogenic supplement for elderly people. Thirteen
physically active male and 12 physically active female seniors (5772 years) were supplemented with 400-mg TA
extract daily for 5 weeks. Standard hematological parameters were taken. In addition, the concentrations of total
and free testosterone, dihydroepiandrosterone, cortisol, insulin-like growth factor-1, and sex hormone-binding
globulin were analyzed. As additional biochemical parameters, blood urea nitrogen and creatine kinase as
parameters of kidney function and muscle damage, respectively, as well as the muscle strength by a simple
handgrip test were determined. After treatment, hemoglobin, testosterone, and dihydroepiandrosterone
concentrations, and the ratio of total testosterone/cortisol and muscle force remained significantly lower in female
seniors than in male seniors. Hematocrit and erythrocyte count in male seniors increased slightly but were
significantly higher than in female seniors. Treatment resulted in significant increases in total and free testosterone
concentrations and muscular force in men and women. The increase in free testosterone in women is thought to be
due to the significant decline in sex hormone-binding globulin concentrations. The study affirms the ergogenic
benefit of TA through enhanced muscle strength. Copyright © 2013 John Wiley & Sons, Ltd.
Keywords: Eurycoma longifolia; adaptogen; testosterone; ergogenic benefits; increased muscle strength; elderly individuals.
INTRODUCTION
Tongkat Ali (TA), Long Jack, or Eurycoma longifolia is a
common herbal shrub found along the slopes of hilly ter-
rains in the Malaysian rainforests (Malaysian Monograph
Committee, 1999; Bhat and Karim, 2010). Its medicinal
value relates to the ground where it is found, and higher
concentrations of phytochemical compounds are found
in the Malaysian Peninsular TA when compared with
TA found elsewhere.
Eurycoma longifolia roots contain a wide variety of
chemical compounds including eurycomaside, tannins,
high molecular weight polysaccharides, glycoproteins,
and mucopolysaccharides, as well as alkaloids of the
quassinoid group (Morita et al., 1993; Jiwajinda et al.,
2001; Ang et al., 2002; Bedir et al., 2003; Miyake et al.,
2009). The active components of TA have been shown
to exert a testosterone-increasing effect (Ali and Saad,
1993; Sambandan et al., 2006; Asiah et al., 2007; Chan
et al., 2009; Tambi et al., 2011). The androgenic effect
of increased serum testosterone is increased muscle
mass, therefore increased potential for generating
greater force in the muscles, evidenced by enhanced
strength (Hamzah and Yusof, 2003). Moreover, TA has
been shown to be a potent herbal energizer (Tambi,
2006a, 2006b), aphrodisiac, pro-fertility, and antiaging
treatment (Ang and Sim, 1998a, 1998b; Ang et al.,
2000; Ang and Ngai, 2001; Tambi, 2005, 2006a, 2006b).
As a result of these known effects of TA, specif ically on
serum testosterone levels, a few studies have investigated
its ergogenic effects on exercise performance in terms of
strength (Bhasin et al., 1996; Hamzah and Yusof, 2003)
and endurance capacity (Ooi et al., 2001, 2003; Muhamad
et al., 2009, 2010). One of the effects of aging is decreased
testosterone levels. Declining testosterone is linked to
loss of muscle mass and muscle strength. Men lose more
muscle mass and strength than women as they age,
suggesting that testosterone contributes to these changes
in physical function (Vermeulen, 2000).
As TA has been shown to enhance serum testosterone
levels, muscle strength should be enhanced, which would
in turn assist elderly people to become or remain physically
active. This study aimed to investigate the usefulness of TA
as an ergogenic supplement to strengthen the muscles of
elderly people.
METHODS
Study design and participants. This was a comparative
study investigating the effects of TA supplementation on
* Correspondence to: Ralf Henkel, Department of Medical Bioscience,
University of the Western Cape, Bellville 7535, South Africa.
E-mail: rhenkel@uwc.ac.za
Ralf R. Henkel and Ruxiang Wang contributed equally.
PHYTOTHERAPY RESEARCH
Phytother. Res. 28: 544550 (2014)
Published online 11 June 2013 in Wiley Online Library
(wileyonlinelibrary.com) DOI: 10.1002/ptr.5017
Copyright © 2013 John Wiley & Sons, Ltd.
Received 05 March 2013
Revised 18 April 2013
Accepted 08 May 2013
various blood parameters taken before supplementation
began and repeated after 3 and 5weeks, respectively.
The participants comprised a total of 25 seniors (13 male
and 12 female), aged between 57 and 72 years, all of
whom were members of a local amateur senior cycling
club in Shenyang, China. Ethical clearance was received
from the Ethics Committee of the Shenyang Center for
Disease Control and Prevention. All volunteers gave
their written informed consent to participate in this study.
Procedure. Supplementation consisted of 400 mg of a
patented (US Patent: 7,132,117) standardized water-
soluble extract of TA (Physta
; Biotropics Malaysia
Berhad, Kuala Lumpur, Malaysia) (200 mg taken twice a
day), for 5 consecutive weeks. A resting, fasting blood
sample was drawn in the morning before the treatment
began (baseline) and after 3 and 5 weeks, respectively. To
assess muscular strength, a simple handgrip dynamometer
test was performed before each blood test. To avoid any
bias with regard to circadian fluctuations of hormonal
levels, medical examination and collection of the blood
samples were always carried out at the same time.
Considering the age of the participants, it was expected
that many of them would have chronic diseases such as
heart disease, high blood pressure, and diabetes, but they
were not excluded because the subjects were physically
active, cycling each day. Because TA is a traditional
remedy, it has been commonly used by many people for
centuries in Southeast Asia, but no studies on possible
contraindications or side effects are available. Participants
were allowed to take the supplement along with their usual
medications. In addition, participants were requested
not to change their normal dietary habits during the time
of supplementation.
The effect of TA supplementation on the levels of
selected hormones, red blood cells (RBCs) and hemoglobin
(HGB), blood urea nitrogen (BUN) level, and creatine
kinase (CK) level of the senior cyclists was evaluated.
Specifically, the following standard blood parameters
were taken: RBC count, HGB concentration, hematocrit
(HCT), white blood cell count, and platelet concentration.
As hormonal parameters, total and free testosterone,
dihydroepiandrosterone-sulfate, and cortisol were examined
in the serum samples. As parameters related to exercise, the
concentrations of BUN, CK, the mean corpuscular HGB,
mean corpuscular HGB concentration, red cell distribution
width, microcorpuscular volume, and the ratio of free
testosterone/cortisol (T/C) were measured. Finally, insulin-
like growth factor-1 and sex hormone-binding globulin
(SHBG) were evaluated. All tests were carried out in
the clinical laboratory according to standard procedures.
To assess the aging health and sexual health of the
subjects, the male participants were asked to f ill out
the Aging MalesSymptoms (AMS) questionnaire
according to Heinemann et al. (1999) before and after
the treatment (Table 1). For the female participants, a
similar questionnaire was developed as Aging Females
Symptoms (AFS) (Table 2). Additionally, a comment
form on the herbal treatment was completed at the
end of the trial, in order to determine if there were
any side effects experienced (Table 3).
Statistical analysis. Statistical analysis of the data was
performed by using MedCalc version 12.0.1 (MedCalc
Software, Mariakerke, Belgium). Data were expressed
as mean SD. After testing for normal distribution by
means of the KolmogorovSmirnov test, parametric
tests, analysis of variance (ANOVA) trend analysis,
and Studentst-test as well as Fishers exact test and
McNemar test were applied. p-values of less than 0.05
were considered significant.
RESULTS
Summary statistics of the study
The patient interviews and physical examinations revealed
that the treatment with 400-mg TA daily for 5 consecutive
Table 1. Answers of male participants to Aging MalesSymptoms questionnaire before and after the 5-week treatment period
Symptoms
Before After
012 3 01 2 3
Decline in your feeling of general well-being 2 3 8 2 5 6
Joint pain and muscular ache 3 4 3 3 3 5 5
Excessive sweating 7 4 2 8 5
Sleep problems 4 5 4 6 5 2
Increased need for sleep, often feeling tired 3 7 3 2 5 6
Irritability 2 7 4 2 9 2
Nervousness 6 5 2 6 7
Anxiety 3 4 4 2 4 6 3
Physical exhaustion/lacking vitality 1 6 6 4 8 1
Decrease in muscular strength 2 5 6 3 8 2
Depressive mood 2 5 4 2 5 4 4
Feeling that you have passed your peak 6 5 2 6 6 1
Feeling burnt out, having hit rock bottom 2 8 3 7 6
Decreased in beard growth 5 6 2 7 5 1
Decrease in ability/frequency to perform sexually 4 9 9 4
Decrease in the number of morning erections 8 5 2 10 1
Decrease in sexual desire/libido 3 10 8 5
0, none; 1, mild; 2, moderate; 3, severe; Fishers exact test, p= 1.0; McNemar test, p= 0.1021.
545TONGKAT ALI AS ERGOGENIC SUPPLEMENT
Copyright © 2013 John Wiley & Sons, Ltd. Phytother. Res. 28: 544550 (2014)
weeks resulted in no side effects in any of the subjects.
Tables 4 and 5 summarize the results of the clinical and
biochemical parameters of the male and female partici-
pants in the study, respectively. The ages of both examina-
tion groups, male and female, were matching (male:
65.9 4.8 years; female: 63.1 4.0 years; and p= 0.1231).
Differences between male and female participants
As expected, before the treatment, female subjects
showed significantly lower values of HGB concentration
(p= 0.0046), white blood cell count ( p=0.0326), total
and free testoster one concentrations ( p<0.0001),
dihydroepiandrosterone concentration ( p=0.0097), the
ratio of total testosterone to cortisol ( p<0.0001), and
muscle strength ( p= 0.0005), as determined by the force
achieved in the handgrip test, compared with the values
of the male participants. For the erythrocyte count
(p= 0.0599) and the HCT ( p= 0.0518), the female partic-
ipants in the study had lower, but not significant,
values than the male participants. In contrast, the serum
concentration of SHBG was significantly ( p=0.0370)
higher in the female participants than in the male
participants.
Effect of Tongkat Ali in female participants
After 5 weeks of treatment with TA, the differences in the
HGB ( p<0.0001), total and free testosterone ( p<
0.0001), and dihydroepiandrosterone concentrations
(p= 0.0398), the ratio of total T/C ( p<0.0001), and the
muscle force as determined in the handgrip test ( p<
0.0001) remained significantly lower in female partici-
pants than in male participants. Additionally, the HCT
and RBC count in the male participants increased
slightly, thus reaching significance when compared with
those levels measured in the female participants
(p= 0.0001 and p= 0.0009, respectively).
Whereas the SHBG levels in the male participants
remained unc hanged ( p= 0.3647) after 5 weeks of
treatment with TA, the serum SHBG concentration in
the female participants decreased significantly ( p<
0.0001) by 20.8% to levels comparable with male partici-
pants (Tables 4 and 5). As a result, no difference
(p= 0.5493) between the serum SHBG levels in male
and female participants was observed.
For the femaleparticipants inthe study, total (ANOVA
trend analysis: p= 0.0098) and free testosterone (ANOVA
trend analysis: p= 0.0001) concentrations and muscle
force (ANOVA trend analysis: p= 0.0641) increased
Table 2. Answers of female participants to Aging FemalesSymptoms questionnaire before and after the 5-week treatment period
Symptoms
Before After
01230 1 23
Heart discomfort 9 2 10 1
Sleep problems 3 7 1 5 6
Depressive mood 4 3 4 6 4 1
Irritability 5 3 3 5 5 1
Anxiety 7 4 9 2
Physical and mental exhaustion 7 3 3 3 5 3
Sexual problems 7 4 2 7 2
Bladder problems 2 4 3 2 3 5 2 1
Dryness of vagina 4 5 2 4 7
Joint and muscular discomfort 3 2 5 1 4 5 2
0, none; 1, mild; 2, moderate; 3, severe; Fishers exact test, p= 0.004; McNemar test, p= 0.0017.
Table 3. Answers to the general questions after the trial
Yes N o
Question Male (n= 13) % Female (n= 11) % Male (n= 13) % Female (n= 11) %
Do you think the supplement is helpful
to your health?
13 100 11 100
Do you feel any improvement in your
desire to actively exercise?
8 61.54 9 81.82 5 38.46 2 18.18
Did you feel any improvement in your
endurance capacity for exercise?
7 53.85 8 72.72 6 46.15 3 27.27
Do you want to continue to use this
supplement?
13 100 11 100
Did you feel hot after taking the supplement? 13 100 11 100
Did you feel dry in your mouth after taking
the supplement?
13 100 11 100
Did you feel a slight headache after taking
the supplement?
13 100 11 100
546 R. R. HENKEL ET AL.
Copyright © 2013 John Wiley & Sons, Ltd. Phytother. Res. 28: 544550 (2014)
Table 4. Effect of Tongkat Ali on clinical and biochemical parameters in men before (baseline), after 3 weeks, and at the end (5 weeks) of
the treatment
Variable (n=13) Baseline 3 weeks 5 weeks (5 week)
p-value
Baseline versus
3 weeks
Baseline versus
5 weeks
Red blood cell count (10
6
/mL) 4.76 0.46 4.89 0.44 4.95 0.35 0.4163 0.1235
Hemoglobin concentration (g/L) 124.00 11.93 129.09 7.45 131.58 8.07 0.0603 0.0093*
Mean corpuscular hemoglobin (pg) 25.36 2.76 26.83 1.26 25.693.85 0.1365 0.8302
Mean corpuscular hemoglobin
concentration (g/L)
261.75 18.05 277.0913.31 273.60 8.67 0.1041 0.1275
Hematocrit (%) 46.193.56 46.73 4.02 47.81 2.60 0.6269 0.1624
Red cell distribution width (%) 14.55 0.24 14.62 0.49 14.66 0.50 0.6061 0.4990
White blood cells count (10
6
/mL) 6.37 1.46 6.14 1.48 6.17 1.38 0.5793 0.4287
Platelets (PLT/L) 143.92 26.91 122.63 24.68 142.6424.61 0.0854 0.8590
Microcorpuscular volume (fL) 95.91 4.74 96.91 4.85 97.36 5.22 0.5356 0.4746
Blood urea nitrogen (mmol/L) 14.98 4.28 16.50 3.43 18.96 3.13 0.4401 0.0117*
Creatine kinase (U/L) 201.72 166.71 112.6836.24 114.11 60.52 0.0887 0.0415*
Total testosterone (ng/mL) 3.84 0.79 4.09 1.02 4.42 1.15 0.2405 0.0090*
Free testosterone (pg/mL) 5.20 1.60 5.99 1.62 8.38 2.18 0.0459* 0.0005*
Dihydroepiandrosterone (mg/mL) 180.55 104.80 197.64 101.48 179.44 101.29 0.5285 0.9603
Cortisol (ng/mL) 201.56 49.34 177.26 41.92 201.69 55.61 0.0650 0.9916
Ratio total testosterone/cortisol 0.020 0.006 0.024 0.007 0.023 0.007 0.0320* 0.0533
Insulin-like growth factor-1 (ng/mL) 174.75 48.39 181.54 32.04 169.21 29.43 0.8645 0.7674
Sex hormone-binding globulin (nmol/L) 45.58 14.61 39.08 13.32 43.01 18.14 0.0776 0.3647
Handgrip test (kg) 46.03 11.30 55.27 11.00 53.67 9.86 0.0135* 0.0375*
*Significant at p<0.05.
Table 5. Effect of Tongkat Ali on clinical and biochemical parameters in women before (baseline), after 3 weeks, and at the end (5 weeks)
of the treatment
Variable (n=12) Baseline 3 weeks 5 weeks
p-value
Baseline versus
3 weeks
Baseline versus
5 weeks
Red blood cell count (10
6
/mL) 4.45 0.28 4.35 0.32 4.41 0.31 0.2309 0.7551
Hemoglobin concentration (g/L) 111.27 6.10 111.467.72 113.91 8.19 0.9264 0.2358
Mean corpuscular hemoglobin (pg) 24.96 0.75 25.66 0.85 25.65 1.33 0.0509 0.0999
Mean corpuscular hemoglobin
concentration (g/L)
265.09 9.79 274.09 9.55 271.54 5.28 0.0295* 0.1305*
Hematocrit (%) 42.74 4.46 41.07 3.18 41.94 2.88 0.2200 0.5637
Red cell distribution width (%) 14.41 0.51 14.34 0.51 14.27 0.59 0.7089 0.3946
White blood cell count (10
6
/mL) 5.20 0.89 5.28 0.76 5.17 0.87 0.6214 0.9113
Platelets (PLT/L) 149.82 27.09 121.82 32.41 125.73 26.90 0.0112* 0.0116*
Microcorpuscular volume (fL) 94.46 3.91 94.54 4.27 109.73 28.67 0.8213 0.1173
Blood urea nitrogen (mmol/L) 14.66 4.04 15.47 4.66 16.82 3.66 0.3949 0.1988
Creatine kinase (U/L) 125.72 73.78 103.93 45.05 81.52 31.14 0.0765 0.0924
Total testosterone (ng/mL) 0.35 0.17 0.44 0.19 0.52 0.30 0.0284* 0.0098*
Free testosterone (pg/mL) 0.50 0.24 0.66 0.38 1.11 0.66 0.0353* 0.0032*
Dihydroepiandrosterone (mg/mL) 88.79 37.09 117.53 77.68 105.63 61.45 0.1019 0.2870
Cortisol (ng/mL) 176.59 54.34 171.42 26.27 187.02 35.90 0.7628 0.4761
Ratio total testosterone/cortisol 0.002 0.001 0.003 0.001 0.003 0.002 0.2482 0.1380
Insulin-like growth factor-1 (ng/mL) 145.27 49.97 134.39 32.93 145.70 43.48 0.3683 0.9694
Sex hormone-binding globulin (nmol/L) 59.66 17.18 50.39 15.85 47.26 16.65 0.0009* <0.0001*
Handgrip test (kg) 29.61 7.28 36.87 8.03 33.67 8.38 0.0069* 0.0641*
*Significant at p<0.05.
547TONGKAT ALI AS ERGOGENIC SUPPLEMENT
Copyright © 2013 John Wiley & Sons, Ltd. Phytother. Res. 28: 544550 (2014)
significantly by 48.6%, 122%, and 13.7%, respectively.
In contrast, significant declines were observed for the
concentration of platelets (decline by 16.1%; ANOVA
trend analysis: p= 0.0116) and SHBG (decline by 20.8%;
ANOVA trend analysis: p<0.0001). Whereas the evalua-
tion of the AFS score revealed significant improvements
(Fishers exact test: p= 0.0040; McNemar test: p= 0.0017),
all other clinical and biochemical parameters were not
influenced by the treatment (Table 2).
Effects of Tongkat Ali in male participants
In men, treatment with TA for 5 weeks resulted in the
significant increases in total (ANOVA trend analysis:
p= 0.0195) and free (ANOVA trend analysis: p=0.0001)
testosterone concentrations and muscular force, as deter-
mined by the handgrip test (ANOVA trend analysis:
p= 0.0602), by 15.1%, 61.1%, and 16.6%, respectively.
In addition, significant increases in the BUN (ANOVA
trend analysis: p= 0.0190) and HGB concentrations
(ANOVA trend analysis: p= 0.0188) by 26.6% and 6.1%,
respectively, were observed. In contrast, CK activity
declined by 43.4% (Table 1), but in the ANOVA trend
analysis, this was not signif icant ( p= 0.9472). All other
clinical and biochemical parameters remained unchanged.
Evaluation of the AMS questionnaire did not reveal any
significant changes (Fishers exact test: p=1.0; McNemar
test: p= 0.1021) (Table 1).
Satisfaction survey
The feedback given by the patients after the treatment
(Table 3) generally revealed affirmative answers, thus
indicating that the treatment subjectively improved the
participantswellness and capacity to do physical exercise.
DISCUSSION
To the best of our knowledge, this is the first study on
TA that evaluates the wellness trend in physically active
seniors. The sample size of the study was small because
of recruitment difficulties, but the subjects recruited
were a very enthusiastic group. They were physically
active, cycling each day, and many of them had chronic
diseases such as heart disease, high blood pressure,
and diabetes and took medicines along with the herbal
supplement. It was noted that the difference in health
conditions and the medicines each subject took some-
what influenced the result. This could probably explain
why the results for some hormone levels in the fifth
week were not as good as in the third week.
Effect on serum testosterone levels
As expected (Tambi et al., 2011), serum testosterone con-
centrations increased significantly in men, but, interest-
ingly, both total and free testosterone also increased
significantly in female participants by 48.6% and 122%
after 5 weeks, respectively. This high increase in free
bioavailable testosterone in female participants cannot
be explained only by the higher concentrations of total
testosterone. Most probably, the decline in serum SHBG
concentrations contributed to the increase in free testos-
terone in female participants. Although significantly
elevated after the treatment with TA, the testosterone
levels (total and free testosterone) in the female partici-
pants were still well within normal physiological levels
of 0.0630.836 ng/mL and 1.08.5 pg/mL, respectively.
Thus, it appears that a potential abuse by athletes (Myhal
and Lamb, 2000) need not be considered.
Muscle strength and potential damage
Even though muscle size was not measured as a parame-
ter, the increase in muscle force, as determined by the
handgrip test, in both genders indirectly reflected an
increased muscle mass and was directly linked to the
significant increase in total and free testosterone concen-
trations. Thus, this study confirms the observations by
Bhasin et al. (1996) as well as Hamzah and Yusof (2003).
In addition, despite the participants being active cyclists,
results demonstrate that the muscles were not being
damaged by the exercise, as evidenced by the drop in
CK enzyme levels (significantly for men). CK is an enzyme
that is released from injured or dying muscle cells and is
therefore regarded as an indicator of muscle damage
(Jones et al., 1986). Furthermore, this study shows that
the ergogenic effects are not only limited to men but also
occur in elderly women, because the serum testosterone
concentrations also increased in the female group.
Nevertheless, this decrease in muscle damage is
accompanied by an increase in BUN levels, which indi-
cates either increased protein catabolism or decreased
kidney function or both. In the urea cycle, nitrogen from
muscle and enteral proteins is converted into urea
(Halperin and Rolleston, 1993). The results of this study
revealed a significant increase in BUN for men over the
5 weeks of TA supplementation and a nonsignificant
increase in women. Considering that, under anabolic
conditions, muscle mass is built up instead of metabolized
and that muscle damage due to exercise after the treat-
ment with TA was decreased, it is unlikely that muscle
protein was being used to produce energy during the
course of this study. Therefore, the BUN levels observed
in this study should be regarded as an indicator of kidney
function (Kuroda et al., 2012) rather than protein catabo-
lism. However, the BUN levels observed in this study,
even after the treatment, were still well within normal
range, and a cause for this increase cannot be explained
by the current data.
Concentration of Tongkat Ali and duration of treatment
On the other hand, other authors did not find any
beneficial effects of TA extract on endurance running ca-
pacity and cycling after administration of either an herbal
ergogenic drink containing 0.001-mg TA/mL (Ooi et al.,
2001, 2003) during the exercise or two TA capsules
(75 mg TA per capsule) daily for 7 days before the
exercise (Muhamad et al., 2010). These authors suggest
that either the total dosage of TA administered was too
low or the period of TA supplementation was too short.
This argument is supported by the current study, where
various parameters show clear trends, either positive or
negative, with the duration of the treatment.
548 R. R. HENKEL ET AL.
Copyright © 2013 John Wiley & Sons, Ltd. Phytother. Res. 28: 544550 (2014)
Effect on hematological parameters
Tongkat Ali had a positive effect on serum HGB con-
centration ( p<0.05 for men). However, no aerobic
measures were taken in the study with which to deter-
mine whether this had a benef icial ergogenic effect.
Although HGB concentration relates directly to the
oxygen-carrying capacity of the blood, one also has to
consider the musclesability to take up and use this
oxygen to produce adenosine triphosphate. This result is
in contrast to those described by Muhamad et al.(2010)
who did not find any influence of TA supplementation
on HGB concentration and HCT. Once again, this might
be due to the period of TA administration being too short
and/or the dose being too low. Similarly, Ooi et al.(2001,
2003) and Muhamad et al. (2009, 2010) have studied the
effects of TA on cycling and running performance and
noted no beneficial effects of acute supplementation,
perhaps because of the dosage being too low. However,
the fact that increased HGB concentrations were seen in
this study warrants further investigation.
Benefits of Tongkat Ali supplementation
During exercise, testosterone and cortisol are affected in
opposite ways, resulting in a change of the hormonal
status from a catabolic state, dominated by cortisol,
toward an anabolic state, dominated by testosterone
(Adlercreutz et al., 1986). Therefore, as a measure to
determine the anabolic/catabolic status of a muscle
during training, the calculation of the T/C ratio has been
suggested (Hakkinen, 1989). The ratio diminishes with
increasing training load and performance capacity
(Hoogeveen and Zonderland, 1996; Mujika et al., 1996)
and is regarded as an indication of overtraining and
fatigue if it decreases below a cutoff level (Adlercreutz
et al., 1986; Hakkinen and Pakarinen, 1991).
In the present study, relevant changes in this parameter
were only observed in men, where a clear trend toward
a higher value after administration of TA was evident.
For women, although a slight increase was observed,
the changes were not significant. Considering that the
increased T/C ratio in men is due to the significantly
increased testosterone levels, this indicates that TA
increases the bodys anabolic status. For elderly men,
hypogonadotropic or infertile patients, this is beneficial
(Tambi and Imran, 2010; Tambi et al., 2011), as it improves
libido, fertility, and well-being (Vermeulen, 2000).
In men, aging symptoms (AMS) in terms of the
questionnaire did not change as one would expect
(Tambi et al., 2011), which was most probably due to
the small sample size. Interestingly, in the female partic-
ipants of the study, the aging symptoms (AFS) improved
significantly. In the literature, information on such an
effect of TA in women is not available. On the contrary,
Wah ab et al. (2010) suggested that TA extract would act as
a potential agent that reverses the inhibitory effects of
estrogen on spermatogenesis in male rats. Unfortunately,
serum estrogen and progesterone concentrations were
not taken as parameters in this study. Therefore, this result
warrants further investigation to elucidate potential
beneficial effects of TA, which, thus far, is said to have
beneficial effects in respect of the well-being in men
(Tambi, 2006a, 2006b) and also in women.
In conclusion, this observational study on the effect of
a standardized water-soluble extract of TA has shown
that the herbal supplement had no adverse effects and
is acceptable to the senior recreational athlete as a form
of health supplement for general well-being. The study
has affirmed the ergogenic benefit of TA for physically
active seniors and has the potential to assist the elderly
to exercise, thereby enhancing health and wellness,
through enhanced muscle strength.
Acknowledgement
The authors wish to thank Biotropics Malaysia Berhad, Kuala
Lumpur, Malaysia, for financially supporting this study.
Conict of Interest
The authors declare not to have any conict of interest.
REFERENCES
Adlercreutz H, Harkonen M, Kuoppaslmi K, et al. 1986. Effect of
training on plasma anabolic and catabolic steroid hormones
and their response during physical exercise. Int J Sports Med
7(Suppl. 1): 2728.
Ali JM, Saad JM. 1993. Biochemical effect of Eurycoma longifolia
Jack on the sexual behavior, fertility, sex hormone and glycolysis.
Dissertation paper for Bachelor of Science, Department of
Biochemistry, University of Malaya.
Ang HH, Cheang HS, Yusof AP. 2000. Effects of Eurycoma
longifolia Jack (Tongkat Ali) on the initiation of sexual
performance of inexperienced castrated male rats. Exp Anim
49:3538.
Ang HH, Hitotsuyanagi Y, Fukuya H, Takeya K. 2002. Quassinoids
from Eurycoma longifolia.Phytochem 59: 833837.
Ang HH, Ngai TH. 2001. Aphrodisiac evaluation in non-copulator
male rats after chronic administration of Eurycoma longifolia
Jack. Fund Clin Pharmacol 15: 265268.
Ang HH, Sim MK. 1998a. Eurycoma longifolia Jack and orientation
activities in sexually experienced male rats. Biol Pharmacol
Bull 21: 153155.
Ang HH, Sim MK. 1998b. Eurycoma longifolia increases sexual
motivation in sexually naive male rats. Arch Pharmacol Res
21: 779781.
Asiah O, Nurhanan MY, Ilham MA. 2007. Determination of
bioactive peptide (4.3 kDa) as an aphrodisiac marker in
six Malaysia plants. J Trop For Sci 19:6163.
Bedir E, Abou-Gazar H, Ngwendson JN, Khan IA. 2003.
Eurycomaoiside: a new quassinoid-type glycoside from the root
of Eurycoma longifolia.Chem Pharmaceut Bull 51: 13011303.
Bhasin S, Storer TW, Berman N, et al. 1996. The effects of
supraphysiologic doses of testosterone on muscle size
andstrengthinnormalmen.New Engl J Med 335:17.
Bhat R, Karim AA. 2010. Tongkat Ali (Eurycoma longifolia Jack): a
review on its ethnobotany and pharmacological importance.
Fitoterapia 81: 669679.
Chan KL, Low BS, Teh CH, Das PK. 2009. The effect of Eurycoma
longifolia on sperm quality of male rats. Nat Prod Commun
4: 13311336.
Hakkinen K, Pakarinen A. 1991. Serum hormones in male strength
athletes during intensive short term strength training. Eur J
Appl Physiol 63: 194199.
Hakkinen K 1989. Neuromuscular and hormonal adaptations
during strength and power training: a review. J Sports Med
Physical Fit 29:926.
Halperin ML, Rolleston FS. 1993. Clinical Detective Stories: A
Problem-Based Approach to Clinical Cases in Energy and
549TONGKAT ALI AS ERGOGENIC SUPPLEMENT
Copyright © 2013 John Wiley & Sons, Ltd. Phytother. Res. 28: 544550 (2014)
Acid-Base Metabolism. 1st edn. London, England: Portland
Press
Hamzah S, Yusof A. 2003. The Ergogenic effects of Tongkat
Ali (Eurycoma longifolia): a pilot study. Br J Sports Med
37(Abstract 007): 464470.
Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C, Hummel
W. 1999. A new aging malessymptomsrating scale. Aging
Male 2: 105114.
Hoogeveen AR, Zonderland ML. 1996. Relationships between
testosterone, cortisol and performance in professional cy-
clists. Int J Sports Med 17: 423428.
Jiwajinda S, Santisopasri V, Murakami A, Hirai N, Ohigashi H.
2001. Quassinoids from Eurycoma longifolia as plant growth
inhibitors. Phytochem 58: 959962.
Jones DA, Newham DJ, Round JM, Tolfree SE. 1986. Experimen-
tal human muscle damage: morphological changes in relation
to other indices of damage. J Physiol 375: 435448.
Kuroda T, Tanabe N, Kobayashi D, Wada Y, Murakami S, Nakano
M, Narita I. 2012. Significant association between renal func-
tion and area of amyloid deposition in kidney biopsy speci-
mens in reactive amyloidosis associated with rheumatoid
arthritis. Rheumatol Int 32: 933939.
Malaysian Monograph Committee. 1999. Radix eurycomae;
eurycoma root. Malaysian Herbal Monograph 1:2932.
Miyake K, Tezuka Y, Awale S, Li F, Kadota S. 2009. Quassinoids
from Eurycoma longifolia.J Nat Prod 72: 21352140.
Morita H, Kishi E, Takeya K, Itokawa H, Iitaka Y. 1993. Squalene
derivatives from Eurycoma longifolia.Phytochem 4: 765771.
Muhamad AS, Chen CK, Ooi FK, Abdullah MR, Chan KL. 2010.
Effects of Eurycoma longifolia Jack supplementation on
recreational athletesendurance running capacity and physical
responses in the heat. Int J Appl Sport Sci 22:119.
Muhamad AS, Chen CK, Ooi FK, Abdullah MR. 2009. Eurycoma
longifolia Jack: medicinal properties and its effect on endurance
exercise performance. Asian J Exer Sports Sci 6:15.
Mujika I, Chatard JC, Padilla S, Guezennec CY, Geyssant A. 1996.
Hormonal responses to training and its tapering off in competitive
swimmers: relationships with performance. Eur J Appl Physiol
Occ Physiol 74: 361366.
Myhal M, Lamb DR. 2000. Hormones as performance enhancing
drugs. In Sport Endocrinology, Warren MP, Constanini NW
(eds). Humana Press: Totowa, NJ; 433476.
Ooi FK, SinghR, Sirishinghe RG, Ang BS, Sahil Jamalullail SM. 2001.
Effects of a herbal ergogenic drink on cycling performance in
young cyclists. Malays J Nutr 7:3340.
Ooi FK, SinghR, Sirishinghe RG, Ang BS, Sahil Jamalullail SM. 2003.
Effects of a herbal drink on cycling endurance performance.
Malays J Nutr 10:7885.
Sambandan TG, Rha C, Aminudim N, Saad JM, Kadir AA.
2006. Bioactive fraction of Eurycoma longifolia.
Patent number: WO0217946; Other reference numbers:
JP2004521075, US2004087493, EP1313491, DK1313491,
DE60125955.
Tambi MI, Imran MK. 2010. Eurycoma longifolia Jack in
managing idiopathic male infertility. Asian J Androl 12:
376380.
Tambi MIM, Imran MK, Henkel RR. 2011. Standardised water-soluble
extract of Eurycoma longifolia, Tongkat Ali, as testosterone
booster for managing men with late-onset hypogonadism?
Andrologia 44(Suppl. 1): 226230.
Tambi MIM. 2005. Standardised water-soluble extract of
Eurycoma longifolia (LJ100) on menshealth.Int J Androl
28(Suppl. 1): 27.
Tambi MIM. 2006a. Standardized water soluble extract of
Eurycoma longifolia (LJ199) maintains healthy aging in man.
Aging Male 9: 53.
Tambi MIM. 2006b. Eurycoma longifolia Jack: a potent
adaptogen in the form of water-soluble extract with the
effect of maintaining menshealth.Asian J Androl 8(Suppl. 1):
4950.
Vermeulen A 2000. Andropause. Maturitas 34:515.
Wahab NA, Mokhtar NM, Halim WN, Das S. 2010. The effect of
Eurycoma longifolia Jack on spermatogenesis in estrogen-
treated rats. Clinics 65:9398.
550 R. R. HENKEL ET AL.
Copyright © 2013 John Wiley & Sons, Ltd. Phytother. Res. 28: 544550 (2014)
... Eurycoma longifolia, commonly referred to as Tongkat Ali, is known for increasing testosterone levels in males, though research has revealed other properties such as its ability to act as an aphrodisiac, pro-fertility, with some research investigating its performance potential by aiding in increased muscular strength, and improved peak power output. 18,28,29 Tongkat Ali is found in several forms including raw powder in capsule form or standardized extracts. 28 Tongkat Ali is believed to be safe as intake is unlikely to lead to fatality in adults with proposed lethal doses being as high as 810 mg/kg. ...
... 18,23 Other research by Tambi et al, 30 found that patients receiving 200 mg of Tongkat Ali via a water-soluble extract for one month had improvements in symptoms of late onset hypogonadism. 30 Henkel et al, 29 had 13 physically active males and 12 physically active females receive 400 mg of Tongkat Ali extract daily for five weeks. Authors noted that Tongkat Ali had the ability to boost testosterone levels and the androgenic effect of this increased testosterone resulted in an increase in muscle mass, increased force, and improved strength. ...
... Authors noted that Tongkat Ali had the ability to boost testosterone levels and the androgenic effect of this increased testosterone resulted in an increase in muscle mass, increased force, and improved strength. 29 At the conclusion of the study, the authors found that both men and women had significant increases in total and free testosterone levels and muscular force. 29 ...
Article
Full-text available
Methods An initial review of the literature published in the last ten years was performed using the databases PubMed and GoogleScholar with search terms including "Testosterone and Ashwagandha" or "Testosterone and Withania som-nifera", "Testosterone and DHEA", Testosterone and Fenugreek", etc. Results Studies have demonstrated the potential benefits of using herbal and nutritional supplements such as Ashwagandha (Withania somnifera), Fenugreek (Trigonella foenum-grae-cum), Tongkat Ali (Eurycoma longifolia Jack), Zinc, and Vitamin D to increase levels of testosterone in men. Conclusions The use of herbal and nutritional supplementation to increase testosterone levels in men with suboptimal levels have shown benefits to both increasing free and total testos-terone levels, but also show added value in improving semen and sperm parameters such as increased sperm concentration, sperm and semen volume, sperm count, sperm motility, and morning erections, with added benefits in reducing body fat, improving strength and muscle mass, improved mood, and decreasing cortisol levels.
... Traditionally, various parts of the plant have been purportedly utilized for their therapeutic properties, including antimalarial, aphrodisiac, anti-diabetic, antimicrobial, and anti-pyretic effects despite the dearth of scientific evidence [1]. Tongkat Ali has been purported to assist with erectile dysfunction [2], increase testosterone concentration [3], and improve mood [4]. To assess the effects of Tongkat Ali in aging males, scientists conducted a 6-month randomized, double-blind, placebo-controlled clinical trial involving 45 men (mean age: 47.38 ± 5.03 years) [5]. ...
... This is the first investigation in trained males and females to show how Tongkat Ali supplementation affects body composition. The theoretical increase in lean body mass has been previously speculated due to the ostensible effect of Tongkat Ali supplementation on testosterone concentrations [3,14]. Nevertheless, our investigation showed that Tongkat Ali supplementation did not affect free testosterone or cortisol. ...
... Henkel et al. examined 13 physically active male and 12 physically active female seniors (57-72 years) who consumed 400 mg of Tongkat Ali extract daily for five weeks [3]. Standard hematological parameters were measured, and the levels of total and free testosterone, dihydroepiandrosterone (DHEA), cortisol, insulin-like growth factor-1 (IGF-1), and sex hormone-binding globulin (SHBG) were analyzed. ...
Article
Full-text available
Background: It has been suggested that supplementation with Tongkat Ali may affect testosterone concentrations; moreover, whether this influences body composition is unclear. Thus, the purpose of this investigation was to determine if four weeks of Tongkat Ali (400 mg daily dose) supplementation affected body composition and salivary free testosterone concentrations. Methods: Thirty-three exercise-trained males (n = 19) and females (n = 14) volunteered for this investigation (mean ± standard deviation: age 33.1 ± 13.0 years; height 171.1 ± 11.3 cm; body mass 77.4 ± 16.8 kg; average total years of training 13.9 ± 13.2; average hours of resistance training/week 4.2 ± 2.5; average hours of aerobic exercise/week 3.4 ± 2.8; average hours of other exercise/week 1.1 ± 2.0). Research participants were pre- and post-tested for body composition (InBody 270), Profile of Mood States (POMS), handgrip strength, and sleep (Pittsburgh Sleep Quality Index [PSQI]). In a subset of the research participants, saliva samples were collected and analyzed for cortisol and free testosterone. The research participants consumed 400 mg of Tongkat Ali or a placebo (rice flour) daily for four weeks. Results: There were no between-group differences (p > 0.05) for body composition (delta score, mean ± SD: lean body mass kg-treatment −0.5 ± 1.9, placebo −0.4 ± 0.7; fat mass kg-treatment −0.5 ± 1.6, placebo 0.3 ± 1.0, % fat treatment −0.1 ± 1.4, placebo 0.5 ± 1.1). Moreover, there were no differences between groups for any additional assessments (e.g., handgrip strength, mood, sleep, and salivary free testosterone and cortisol). Conclusions: Four weeks of supplementation with Tongkat Ali in exercise-trained males and females does not affect body composition, mood, sleep, vigilant attention, handgrip strength, cortisol, and free testosterone.
... Characteristics of the included studies (n = 9) are reported in Table 1. There were three studies that investigated a male population affected by hypogonadism [26][27][28], while six studies included a population of healthy men with normal testosterone levels [29][30][31][32][33][34]. E. longifolia was investigated primarily as a commercial water-extracted product (Physta ® , Biotropics, Berhad, Kuala Lumpur, Malaysia) in seven of the nine studies included [26,27,[29][30][31][32][33], with variable dosages from 100 to 600 mg/daily for a minimum of 3 days to a maximum of 6 months ( Table 1). ...
... There were three studies that investigated a male population affected by hypogonadism [26][27][28], while six studies included a population of healthy men with normal testosterone levels [29][30][31][32][33][34]. E. longifolia was investigated primarily as a commercial water-extracted product (Physta ® , Biotropics, Berhad, Kuala Lumpur, Malaysia) in seven of the nine studies included [26,27,[29][30][31][32][33], with variable dosages from 100 to 600 mg/daily for a minimum of 3 days to a maximum of 6 months ( Table 1). ...
... Most of the studies (n = 7) reported a significant improvement in total testosterone levels after E. longifolia treatment [26][27][28][29][30]33,34]. However, two studies failed to observe any improvement in testosterone levels when the treatment was stopped after 3 weeks [30] or prolonged to 8 weeks [34]. ...
Article
Full-text available
Background and Objectives: Male hypogonadism is a clinical disorder characterized by reduced serum testosterone in men. Although treatment using herbal medicines, including Eurycoma longifolia, has been investigated, the benefits remain unclear. This study aims to investigate the efficacy of E. longifolia as a sole intervention to increase testosterone levels in males. Materials and Methods: We conducted a systematic review and meta-analysis of randomized clinical trials (RCTs) according to the PRISMA guidelines. Relevant articles were retrieved from the databases PubMed, Scopus, Web of Science, Cochrane, Ovid/Embase, and Google Scholar. Results: After literature screening, a total of nine studies was included in the systematic review. Five RCTs were included in the meta-analysis. A significant improvement in total testosterone levels after E. longifolia treatment was mostly reported in both healthy volunteers and hypogonadal men. The random model effect revealed a significant increase (SMD = 1.352, 95% CI 0.565 to 2.138, p = 0.001) in the total testosterone levels in men receiving E. longifolia supplementation, which was confirmed in the hypogonadism subgroup. Conclusions: This systematic review and meta-analysis of the literature supports the possible use of E. longifolia supplementation for enhancing testosterone production. Although more research is required before its use in clinical practice, this may represent a safe and promising therapeutic option, particularly in hypogonadal men.
... The amount of the supplement was 400 mg per day for 7 days, and the participants took 200 mg (2 capsules) in the morning and 200 mg (2 capsules) in the afternoon with 250 ml of water for each occasion. This amount was chosen as it has been shown to increase testosterone and muscular strength [13], and has been demonstrated to be safe for long-term use [3]. ...
... The current study had some limitations. First, the supplementation period was relatively short (one week) in comparison with previous studies in which the supplementation period was more than 4 weeks [5,13]. This could have restricted potential positive results of the supplement. ...
Article
Full-text available
Eurycoma longifolia Jack (ELJ) is a herbal plant that has androgenic and antioxidant effects. We investigated the short-term effect of ELJ supplementation on muscle damage induced by eccentric exercise. Eighteen young (19–25 years), well-trained rugby 7s players were assigned to an ELJ or a placebo (PLA) group (n = 9/group). Each participant took four 100-mg capsules a day for seven days prior to performing a leg press eccentric exercise to failure in a double-blind fashion. Peak force, peak power and jump height in countermovement jump (CMJ), drop jump reactive strength index (RSI), muscle soreness assessed by a 100-mm visual analogue scale, plasma creatine kinase (CK) activity, and salivary hormones were measured at 24 h before and 0.5, 24, 48, 72, and 96 h after the exercise. Changes in the variables over time were compared between the groups by two-factor mixed-design ANOVA. The number of eccentric contractions performed was similar (P = 0.984) between the ELJ (21 ± 5) and PLA groups (21 ± 5). Salivary testosterone and cortisol concentrations did not change (P > 0.05) after the supplementation for both groups. CMJ peak power (-9.4 ± 5.6%) and height (-10.6 ± 4.9%), and RSI (-15.2 ± 16.2%) decreased at 24 h after exercise (P < 0.05), and muscle soreness (peak: 89 ±10 mm) and plasma CK activity (peak: 739 ± 420 IU/L) increased after exercise (P < 0.05) without significant differences between groups. These results showed that 7-day ELJ supplementation prior to the leg press eccentric exercise had no significant effects on hormones, performance and muscle damage markers for the athletes.
... This herb contains small peptides known as "eurypeptides", which have been shown to enhance energy status and sex drive in rodent studies [54]. In human studies, four comparative and follow-up studies on healthy men, infertile individuals, and men with hypogonadism [55,56,57,58] have demonstrated favorable outcomes in terms of both sex hormones and sperm quality. Eurycoma longifolia has been shown to improve semen quality by reducing oxidative stress owing to its rich antioxidant properties [59]. ...
Article
Full-text available
Background: The increasing prevalence of male infertility has become a global concern. Traditional Chinese and Asian medicines have long been using herbal remedies to promote spermatogenesis. This study aimed to systematically explore the potential of herbal medicines and formulations to enhance the male reproductive function in humans. Methods: Two prominent databases, MEDLINE and EMBASE, as well as scientific journals indexed in the Web of Science, were used for the literature search until October 2023. The studies included in the analysis focused on the impact of herbal medicines (Mucuna pruriens, Withania somnifera, Eurycoma longifolia, Panax ginseng, Lyco-persicon esculentum, Crocus sativus, Vitis vinifera, Nigella sativa, Sesamum indicum, Curcuma longa, Lepidium peru-vianum) and Chinese and Korean Polyherbal formulations (Shao-Fu-Zhu-Yu-Tang; 少腹逐瘀汤) on human serum reproductive hormone levels, semen parameters, and antioxidant enzymes. Results: A total of 23 articles were deemed eligible for the review and meta-analysis, which included 1,194 men from seven countries (China, Korea, Iran, Peru, Japan, Malaysia, and India). Of these, 19 articles were analyzed for semen parameters. The use of herbal medicine increased seminal parameters, including semen volume during each ejaculation (standardized mean difference (SMD) = 0.89; 95 % CI: 0.52, 1.26), sperm concentration (SMD = 1.97; 95 % CI: 1.30, 2.64), total sperm count (SMD = 2.28; 95 % CI: 1.44, 3.11), sperm motility (SMD = 1.07; 95 % CI: 0.68, 1.46), and normal morphology (SMD = 1.47; 95 % CI: 0.62, 2.32). Additionally, 18 articles that analyzed sex hormone levels showed that treatment with herbal medicines favorably reduced serum prolactin (SMD =-0.70; 95 % CI:-1.13,-0.28) and FSH levels (SMD =-1.07; 95 % CI:-1.56,-0.56). Meanwhile, herbal medicines did not affect testosterone levels (SMD = 0.41; 95 % CI:-0.24, 1.06) and LH levels (SMD = 0.45; 95 % CI:-0.33, 1.23). Finally, six articles were analyzed for seminal biochemical and antioxidant profiles, and the results showed that herbal medicine increased the levels of ascorbic acid (SMD = 1.19; 95 % CI: 0.51, 1.86), corrected seminal fructose (SMD = 1.32; 95 % CI: 0.89, 1.76), superoxide dismutase activity (SOD) (SMD = 1.06; 95 % CI: 0.45, 1.68), and catalase activity (SMD = 0.91; 95 % CI: 0.69, 1.44) in seminal plasma. Conclusion: Herbal remedies have been found to promote spermatogenesis by optimizing semen parameters, sex hormone levels, and antioxidant profiles. As a result, these treatments should be regarded as complementary approaches to male infertility.
... Henkel et al. conducted a study with 25 healthy participants (physically active 13 men, 12 women without sexual complaints) between the ages of 57 and 72. For 5 weeks, participants consumed 200 mg of Eurycoma extract twice a day [72]. Prior to therapy, total and free testosterone and dehydroepiandrosterone (DHEA) blood concentrations were determined in the participants. ...
Article
Since time immemorial, people have been trying to influence different aspects of their sexuality. They seek ways to increase sexual activity or sexual desire in themselves and their partners. In addition to resorting to all sorts of mystical rituals, people were looking for various effects from the use of natural raw materials. Some plant, animal, or fungal products have been shown to affect libido, sexual arousal, erectile function, orgasm or erogenous zone sensitivity. Such substances have been called "aphrodisiacs" in honor of the ancient Greek goddess of love - Aphrodite. Most often, aphrodisiacs were taken orally, but some were smoked while others applied to the genitals. In modern clinical practice, phosphodiesterase type 5 inhibitors are used. These are substances, which enhance erection and prevent detumescence in the presence of sexual arousal. Another group of drugs is selective serotonin reuptake inhibitors, which reduce sexual arousal and sexual afferent from the genitals, thus preventing the premature onset of orgasm in men and prolonging sexual intercourse. However, drugs from other pharmacological groups have not found widespread clinical application. Another issue now is a trend among people taking drugs of natural origin, therefore, all kinds of traditional aphrodisiacs are actively used to the present day. Very little is known about almost all of them. Clinical trials are in most cases limited to a few, often not randomized, studies. In this regard, it is very difficult to evaluate the adequate therapeutic and toxic doses of remedies. The situation is complicated by the fact that those few clinical studies were based on questionnaires, that is, the indicators taken into statistical calculations were extremely subjective. Moreover, it was uncertain whether all patients could adequately assess their dynamics in terms of parameters such as sexual satisfaction, or clearly distinguish between libido and sexual arousal. Since the majority of the studies were not blinded, a psychogenic influence on the results of the investigations could not be eliminated, which in the sexual area may be huge. It is worth emphasizing the toxicity of many traditional aphrodisiacs. Of course, there is a serious deficit in the spectrum of pharmacotherapy for sexual disorders. Perhaps further large, randomized, placebo-controlled trials would add some of the traditional aphrodisiacs or their modifications to the arsenal of the clinical specialist.
Article
Tongkat Ali (TA), also known as Eurycoma longifolia, has been used as a traditional herbal medicine for anti-aging, evidenced by clinical trials presenting the beneficial effects on energy, fatigue, and mood disturbance. We have recently shown that TA supplementation dose-dependently enhances the rest–activity pattern in C57BL/6 mice. Since destabilization of wakefulness and sleep is one of the typical symptoms of not only the elderly but also narcolepsy, we performed sleep analysis with and without dietary TA extract supplementation in middle-aged (10–12 months old) wild-type (WT) and narcoleptic DTA mice. We found that TA supplementation enhanced diurnal rhythms of locomotion and temperature in a time-of-day-dependent manner in WT mice but attenuated in DTA mice. In WT mice, TA supplementation consolidated wakefulness with a long bout duration and led to less entries into the sleep state during the active period, while it consolidated NREM sleep with long bout duration during the resting period. Neither disturbed sleep and wake cycles nor cataplexy was sufficiently improved in DTA mice. EEG spectral analysis revealed that TA supplementation enhanced slow wave activity (SWA) at both delta and low delta frequencies (0.5–4.0 and 0.5–2.0 Hz) during the light period, suggesting TA extract may induce vigilance during the active period, which then elicits a rebound effect during the resting period. Interestingly, DTA mice also slightly, but significantly, increased SWA at low frequencies during the light period. Taken together, our results suggest that TA supplementation enhances the Yin-Yang balance of sleep, temperature, and locomotion in WT mice, while its efficacy is limited in narcoleptic mice.
Article
Full-text available
Photoreceptor degeneration decreases light sensitivity and leads to vision loss and various retinal diseases. Neurotrophin-3, originating from Müller glial cells in the retina, plays a key role in protecting photoreceptors from damage induced by light or hypoxia. This neuroprotective approach is important because there are no established methods to regenerate lost photoreceptors. Dietary supplements are one of the useful methods for improving eye health. Eurycoma longifolia Jack, which is native to the tropical forest of Malaysia and other Southeast Asian countries, exhibits several medicinal properties. In the present study, we demonstrated that the water extract of E. longifolia roots enhanced neurotrophin-3 gene expression in primary rat Müller cells. Using a stepwise bioassay-guided fractionation and purification of E. longifolia root extracts, we isolated the active compound underlying neurotrophin-3 gene-enhancing activities. Mass spectrometry and nuclear magnetic resonance spectral data identified the compound as eurycomanone. This study provides evidence for the efficacy of E. longifolia and eurycomanone in enhancing neurotrophin-3 expression in Müller cells in vitro. Although the biological significance of this effect and its underlying mechanism remain to be elucidated, this study suggests that E. longifolia may be promising for improving eye health and must be further investigated.
Article
Full-text available
This review article discusses the medicinal properties of a herbal plant, Eurycoma longifolia Jack, and its possible ergogenic effect on endurance exercise performance. To date, herbs or plant products that have been investigated as ergogenic aids for enhancing endurance performance are caffeine, ginseng, mahuang, ephedrine and related alkaloids. Eurycoma longifolia Jack is one of the herbs found in Malaysia. It is commonly known as ‘Tongkat Ali’ in Malaysia and as ‘Pasak Bumi’ in Indonesia. It is also referred to as ‘Malaysian ginseng’ since it is well-known among various ethnic groups in Malaysia for treating various diseases and enhancing health. Eurycoma longifolia Jack is a tall, slender shrubby tree found on sandy soil. It belongs to the Simaroubaceae family and grows wildly in Southeast Asian countries, i.e. Malaysia, Indonesia, Thailand, and Myanmar. To our knowledge, studies on Eurycoma longifolia Jack as an ergogenic aid for enhancing endurance performance is lacking. Thus, this review article highlights the available studies on its purported medicinal properties as well as studies that have been carried out to investigate its effects on physiological responses and endurance exercise performance.
Article
Full-text available
This study investigated the effects of supplementation of the nutraceutical product Eurycoma longifolia Jack on recreational athletes’ endurance running capacity and physiological responses in the heat. Twelve Malaysian healthy male recreational athletes (Age: 23.3 (3.7) years old; VO2max: 45.1 (8.1) ml.kg-1.min-1) were recruited in this double blind, placebo-controlled, cross-over study. Subjects completed two endurance running trials in the heat (31°C, 70% relative humidity), performed on separate days, after consuming either 2 capsules of Eurycoma longifolia Jack (75 mg per capsule) or a placebo per day for 7 days before and one hour prior to the experimental trial. On trial day, after 5 minutes of warm-up at 50 % VO2max, the subjects were requested to run on the treadmill at 60 % VO2max for 60 minutes. This was immediately followed by a 20-minute time trial for determining endurance running capacity. Blood samples were taken before warm up, after warm-up, and every 20 minutes during the trial. Statistical analysis was performed using one-way ANOVA with repeated measures. Results showed that the endurance running capacity of E. longifolia was not significantly different from that of the placebo trial. Similarly, oxygen uptake, heart rate, skin temperature, tympanic temperature, ratings of perceived exertion, haemoglobin concentration, haematocrit level, plasma glucose concentration, and plasma free fatty acid concentration were not significantly different between the trials. These findings suggested that supplementation of the E. longifolia product at a dosage of 150 mg.day-1 for 7 days has not provided beneficial effects on endurance running capacity and physiological responses of recreational athletes in the heat. Higher dosage and longer duration of supplementation of the product may be warranted to evaluate further its endurance capacity during exercise.
Chapter
Numerous publications have addressed the medical, ethical, and legal issues surrounding nonmedical hormone use by healthy individuals. The ethical and legal implications of hormone use in sports to enhance performance are clear—it is unethical and illegal. However, the medical implications surrounding this practice are far less certain, particularly when hormones are used to enhance appearance or performance in noncompetitive athletic settings. A considerable amount of misinformation exists among both users and their primary-care physicians. Many in the medical/scientific community are unaware of why some of these drugs are used, their basic mechanisms of action, and differences among agents within a class of drugs, such as anabolic-androgenic steroids. In addition, sensationalistic media coverage and anecdotal case reporting have further clouded our understanding of performance-enhancing drugs, has impeded research, and has suppressed potentially important clinical applications of these agents. Therefore, the purpose of this chapter is to 1. Provide an overview of hormones and related drugs commonly used to enhance performance and/or physical appearance; 2. Provide a critique of the various rationales given by individuals to support their use of performance-enhancing drugs; and 3. Discuss the basis for the prevailing dogmas surrounding the nonmedical use of hormones, particularly those involving side effects and overall risk.
Article
IntroductionErectile dysfunction (ED) affects quality of life in patients treated by radical prostatectomy (RP). The Erection Hardness Score (EHS) is a single-item scale that has demonstrated good psychometric properties for assessing erectile function (EF) in patients treated by sildenafil, but its applicability to other treatment contexts has not yet been tested.AimThis study aims to test the validity and time and treatment responsiveness of the EHS to assess ED in men with post-RP ED treated with alprostadil injections.Methods This is a 1-year follow-up cohort study of 75 patients treated by RP for localized prostate cancer in a urology department setting between January 2007 and December 2008. Data were prospectively collected at 6 and 12 months post-RP.Main Outcome MeasuresThe EHS, the International Index of Erectile Function (IIEF) reference questionnaire, the Global Assessment Questionnaire (GAQ), and Numeric Pain Scale (NPS) were collected. Convergent validity (Spearman correlation coefficients with IIEF domains), known-groups validity (comparing EHS scores across ED severity groups), time and treatment responsiveness (effect size with/without treatment and over the follow-up period), and predictive ability (area under the receiver operating characteristics curve [AUC-ROC]) were analyzed for this study.ResultsThe EHS showed good convergent validity (all Spearman coefficients significant at the P < 0.05 level), adequate known-groups validity (global differentiation between IIEF-EF severity groups; P < 0.001), and treatment responsiveness (effect size: +1.8 [6 months], +2.1 [12 months]), but limited time responsiveness and predictive ability of the EHS for a normal EF at 12 months follow-up when compared with the IIEF-EF domain (AUC-ROC: 0.72 vs. 0.85; P < 0.01).Conclusion Our findings support the overall good psychometric properties of the EHS in patients with post-RP ED treated with alprostadil injections. However, evidence for limited predictive validity and responsiveness to change over time should be considered for its use in clinical follow-up in this population. Parisot J, Yiou R, Salomon L, de la Taille A, Lingombet O, and Audureau E. Erection hardness score for the evaluation of erectile dysfunction: Further psychometric assessment in patients treated by intracavernous prostaglandins injections after radical prostatectomy. J Sex Med **;**:**–**.
Article
Unlike in women, where instruments are available to measure the severity of symptoms, standardized instruments are lacking for aging males. However, a new ‘aging males’ symptoms' (AMS) rating scale has been developed in the present study, as well as reference values. A total of 116 medically well-characterized males (aged over 40 years) were recruited to complete a questionnaire of symptoms, the prevalence of which commonly changes with increasing age. Factor analysis was used to establish the raw scale and to identify the dimensions of the scale. This raw scale was applied to a large representative population sample of 992 German males, to establish reference values for the severity of symptoms in males over 40 years. Three dimensions of symptoms were identified in the patient group: a psychological, a somatovegetative and a sexual factor, that explained 51.6% of the total variance. Reference values of the three dimensions were defined to be used in daily practice. The severity of symptoms assessed using the AMS scale was found to be related to the clinically defined ‘male climacteric’ in the patient group. The AMS scale is a new and valuable tool for assessing aging males' symptomsc and can be easily used in practice.